Autoimmune bullous diseases are often associated with significant morbidity and some can even cause mortality, if left untreated. Multiple therapies are now available to treat these blistering ...

Dupilumab use among adults with bullous pemphigoid was associated with significant improvements in several efficacy measures, with no new safety signals identified. Dupilumab offers significant ...